Products
Periods:
| Test name | Registration | Year | Methods | Entities | Availability | Accredited status DIN EN ISO/IEC 17043:2023 | Price | Code | ||
|---|---|---|---|---|---|---|---|---|---|---|
Trial A only DACH | 05.01.2026 - 30.09.2026 | 2026 | IHC | Kopf-Hals | DACH | Not Accredited | €0.00 - €100.00 | trial-a | ||
ASD Untertitel | 28.07.2025 - 31.12.2026 | 2026 | ISH | — | International DACH | Not Accredited | €0.00 | asd | ||
Neuroendokrine Marker (IHC) Synatophysin, Chromogranin, Ki-67 (Mandatory Package); Calcitonin; Serotonin | 05.01.2026 - 31.12.2026 | 2026 | IHC | Neuroendokrine Tumor | DACH International | Accredited | €200.00 - €400.00 | nem-ihc-25 | ||
Lymphome (IHC) CD20, CD3, CD5 und CyclinD1 | 05.01.2026 - 21.01.2027 | 2026 | IHC | Lymphome | DACH | Accredited | €400.00 - €900.00 | lymph-basic-ihc-25 | ||
Keratine Prostatakarzinom / Keratins Prostate Carcinoma (IHC) Pan-Keratine, Basal Cell Marker, Keratine 7, Keratine 20, Racemase and Prostate Specific Marker | 19.01.2026 - 31.07.2026 | 2025 | IHC | Prostata | — | Accredited | €650.00 | keratine-ihc-26 | ||
ESP/QuIP Lung Cancer Related Markers ALK ISH, ALK IHC, ROS1 ISH, ROS1 IHC | 01.12.2025 - 29.08.2026 | 2025 | ISH IHC | Lunge / Lung | — | Accredited | €420.00 - €470.00 | esp-ish-ihc-25 | ||
Trial-correct-shipping Trial with correct shipping | 01.12.2025 - 31.12.2026 | 2026 | NGS | Prostata | DACH International | Accredited | €500.00 | trial-shipping | ||
Free-Shipping Free-Shipping | 15.06.2026 - 31.07.2026 | 2026 | ISH | Gyn | DACH International | Not Accredited | €0.00 | free-shipping | ||
Trial pay but free shipping Trial pay but free shipping | 14.06.2026 - 31.07.2026 | 2026 | IHC | Lunge / Lung | DACH International | Accredited | €100.00 | trial-pay-free-ship | ||
Multisection IHC A, B, C | 01.07.2026 - 01.01.2027 | 2026 | IHC | — | DACH International | Accredited | €250.00 - €500.00 | multi-ihc-26 | ||
Sorting Variant Test Sort Variant | 03.07.2026 - 03.07.2026 | 2026 | IHC | — | International DACH | Accredited | €0.00 | sort-var-26 | ||
esr1 | 07.09.2026 - 21.10.2026 | 2026 | Molpath LB | Neuroendokrine Tumor | International | Not Accredited | €500.00 | esr1-int-lb | ||